Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-302-7 | CAS number: 80-70-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 3 June 2015 - 11 June 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline Study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted in 21st July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- dated 30th May 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ICH Guidance S2(R1): Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use, 2012
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Gyemszi, Budapest, Hungary
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 1,1,3,3-tetramethylguanidine
- EC Number:
- 201-302-7
- EC Name:
- 1,1,3,3-tetramethylguanidine
- Cas Number:
- 80-70-6
- Molecular formula:
- C5H13N3
- IUPAC Name:
- N,N,N',N'-tetramethylguanidine
- Details on test material:
- - Name of test material (as cited in section 1): 1,1,3,3-Tetramethylguanidine
Constituent 1
Method
- Target gene:
- his and trp operon
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital and β-naphthoflavone
- Test concentrations with justification for top dose:
- 16, 50, 160, 500, 1600 and 5000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water (ultrapure)
- Justification for choice of solvent/vehicle: ultrapure water was found as suitable vehicle for preparing the test item solutions in a preliminary solubility test
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: -S9: 9-aminoacridine (50 µg/plate) for TA1537; 4-nitro-1,2-phenylenediamine (4 µg/plate) for TA98; sodium azide (2 µg/plate) for TA100 and TA1535; methyl methanesulfonate (2 µL/plate) for E. coli; +S9: 2-aminoanthracene (2 or 50 µg/plate) for all strains
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation; initial mutation test) and preincubation (confirmatory mutation test)
DURATION
- Preincubation period: 20 min
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: triplicate
DETERMINATION OF CYTOTOXICITY
- Method: decreased or absent revertant colony counts and affected background lawn development - Evaluation criteria:
- A test item is considered mutagenic if:
- a dose–related increase in the number of revertants occurs and/or;
- a reproducible biologically relevant positive response for at least one of the dose groups occurs in at least one strain with or without metabolic activation.
An increase is considered biologically relevant if:
- in strain TA98, TA100 and E. coli WP2 uvrA the number of reversions is at least twice as high as the reversion rate of the vehicle control
- in strain TA1535, TA1537 the number of reversions is at least three times higher than the reversion rate of the vehicle control.
According to the guidelines, the biological relevance of the results is the criterion for the interpretation of results, a statistical evaluation of the results is not regarded as necessary.
Criteria for a negative response: a test item is considered non-mutagenic if it produces neither a dose-related increase in the number of revertants nor a reproducible biologically relevant positive response at any of the dose groups, with or without metabolic activation
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- in the confirmatory mutation test at 5000 μg/plate ±S9 mix
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: soluble
- Precipitation: no precipitation of the test item was observed in the initial and confirmatory mutation tests on the plates in the examined bacterial strains at any examined concentration level (±S9 mix)
RANGE-FINDING/SCREENING STUDIES: based on the results of the solubility and the range finding tests the vehicle (ultrapure water) and the test item concentrations for both mutation tests were determined (16, 50, 160, 500, 1600 and 5000 µg/plate)
COMPARISON WITH HISTORICAL CONTROL DATA: yes
ADDITIONAL INFORMATION ON CYTOTOXICITY: in the confirmatory mutation test, following the pre-incubation procedure an inhibitory effect of the test item on bacterial growth was observed in all examined strains at the highest examined concentration of 5000 μg/plate in absence and also in the presence of exogenous metabolic activation (±S9 mix) - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1: Test Results of Experiment 1
EXPERIMENT 1 (plate incorporation test; initial mutation test) |
|||||
S9-Mix |
Without
|
||||
Test item (µg/plate) |
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
E. coli |
NC (DMSO) |
18.3±1.53 |
- |
- |
9.7±3.06 |
- |
NC (water) |
20.7±4.73 |
93.0±5.29 |
11.7±4.93 |
8.3±3.79 |
20.3±2.52 |
5000 |
13.3±2.31 |
87.7±15.14 |
12.3±4.73 |
9.0±1.73 |
19.0±6.24 |
1600 |
22.3±3.51 |
95.3±12.01 |
11.0±3.61 |
7.7±1.15 |
16.7±4.51 |
500 |
17.0±2.65 |
93.3±10.69 |
10.3±3.21 |
7.3±3.21 |
17.3±1.53 |
160 |
16.0±3.61 |
86.7±7.77 |
14.7±2.08 |
9.0±1.73 |
15.7±3.21 |
50 |
17.0±2.65 |
83.0±3.61 |
9.0±3.00 |
10.3±2.31 |
23.0±6.93 |
16 |
16.7±2.89 |
91.7±2.08 |
10.3±1.53 |
9.7±3.51 |
15.3±0.58 |
NPD |
269.3±21.57 |
- |
- |
- |
- |
SAZ |
- |
1089.3±55.47 |
900.0±203.45 |
- |
- |
9AA |
- |
- |
- |
734.0±104.10 |
- |
MMS |
- |
- |
- |
- |
587.3±17.24 |
2AA |
- |
-- |
- |
- |
- |
S9-Mix |
With
|
||||
|
|
|
|
|
|
Test item (µg/plate) |
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
E. coli |
NC (DMSO) |
24.3±2.89 |
101.0±7.94 |
12.7±4.04 |
7.7±2.52 |
20.7±5.86 |
NC (water) |
27.3±5.13 |
100.3±15.57 |
8.3±2.89 |
10.7±3.79 |
24.0±3.61 |
5000 |
21.7±2.31 |
86.0±21.93 |
12.7±1.15 |
11.0±3.46 |
23.3±2.52 |
1600 |
27.0±4.58 |
106.3±6.81 |
9.3±0.58 |
8.7±5.51 |
22.0±2.00 |
500 |
32.0±10.00 |
111.0±13.53 |
10.0±3.00 |
9.0±3.00 |
20.7±4.51 |
160 |
28.0±5.29 |
114.0±3.46 |
9.0±3.00 |
10.3±0.58 |
22.7±4.93 |
50 |
25.3±8.09 |
98.7±5.51 |
7.0±1.00 |
8.7±4.04 |
22.3±4.62 |
16 |
21.0±6.24 |
102.0±11.53 |
10.0±5.20 |
11.3±5.77 |
21.0±5.00 |
NPD |
- |
- |
- |
- |
- |
SAZ |
- |
- |
- |
- |
- |
9AA |
- |
- |
- |
- |
- |
MMS |
- |
- |
- |
- |
- |
2AA |
1232.0±215.70 |
1669.3±224.19 |
163.3±54.17 |
103.30±5.03 |
336.0±45.08 |
NC = Negative/Vehicle Control PC = Respective positive control substances (for details see method description) |
|||||
Ultrapure water was applied as vehicle for the test item and the positive control substances SAZ and MMS; DMSO was applied as vehicle for the positive control substances NPD, 9AA and 2AA. |
Table 2: Test Results of Experiment 2
EXPERIMENT 2 (preincubation; confirmatory mutation test) |
|||||
S9-Mix |
Without
|
||||
Test item (µg/plate) |
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
E. coli |
NC (DMSO) |
15.7±0.58 |
- |
- |
13.0±3.00 |
- |
NC (water) |
18.3±5.13 |
85.7±5.13 |
11.0±3.61 |
14.0±2.00 |
20.3±2.52 |
5000 |
0.0±0.00B |
0.0±0.00B |
0.0±0.00B |
0.0±0.00B |
8.0±2.65SB |
1600 |
15.7±8.33 |
94.0±12.17 |
13.7±3.06 |
8.3±2.08 |
13.7±3.79 |
500 |
22.7±1.15 |
84.7±16.29 |
13.7±3.79 |
13.0±5.29 |
20.3±4.93 |
160 |
22.3±7.57 |
87.0±5.57 |
13.0±3.61 |
12.3±4.51 |
21.7±0.58 |
50 |
13.7±0.58 |
89.3±1.15 |
16.0±2.65 |
15.0±2.65 |
21.0±1.00 |
16 |
19.3±8.39 |
95.0±7.81 |
9.7±1.53 |
13.0±1.73 |
18.0±4.36 |
NPD |
249.3±23.18 |
- |
- |
- |
- |
SAZ |
- |
1241.3±231.80 |
1456.0±169.33 |
- |
- |
9AA |
- |
- |
- |
1933.3±59.28 |
- |
MMS |
- |
- |
- |
- |
752.0±124.96 |
2AA |
- |
-- |
- |
- |
- |
S9-Mix |
With
|
||||
|
|
|
|
|
|
Test item (µg/plate) |
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
E. coli |
NC (DMSO) |
24.3±2.52 |
94.0±19.16 |
10.7±3.51 |
10.7±1.15 |
20.0±4.36 |
NC (water) |
30.3±2.52 |
94.7±6.11 |
14.0±2.00 |
11.3±3.79 |
21.0±4.00 |
5000 |
3.7±6.35B |
0.0±0.00B |
0.0±0.00B |
0.0±0.00B |
0.0±0.00B |
1600 |
27.0±7.94 |
113.3±9.87 |
9.0±5.00 |
7.7±4.73 |
17.3±2.89 |
500 |
24.3±6.11 |
96.7±12.86 |
14.0±1.73 |
9.7±1.53 |
21.7±1.15 |
160 |
26.0±4.36 |
119.3±2.31 |
13.0±4.36 |
12.0±1.00 |
21.0±2.65 |
50 |
19.3±4.51 |
115.7±7.64 |
14.3±4.62 |
12.0±5.57 |
20.0±4.36 |
16 |
21.7±8.33 |
108.0±5.29 |
11.7±4.62 |
10.7±2.52 |
20.0±2.00 |
NPD |
- |
- |
- |
- |
- |
SAZ |
- |
- |
- |
- |
- |
9AA |
- |
- |
- |
- |
- |
MMS |
- |
- |
- |
- |
- |
2AA |
1280.0±42.33 |
1636.0±130.05 |
135.7±15.95 |
102.0±4.36 |
118.0±31.05 |
NC = Negative/Vehicle Control PC = Respective positive control substances (for details see method description) B = Reduced background lawn development SB =Slightly reduced background lawn development |
|||||
Ultrapure water was applied as vehicle for the test item and the positive control substances SAZ and MMS; DMSO was applied as vehicle for the positive control substances NPD, 9AA and 2AA. |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
The test item LZ 754 has no mutagenic activity on the applied bacterium tester strains under the test conditions used in this study. - Executive summary:
The study was performed in year 2015 according to GLP and OECD Guideline 471. No biologically relevant increases were observed in revertant colony numbers of any of the five test strains following treatment with LZ 754 at any concentration level, either in the presence or absence of metabolic activation (S9 Mix) in the performed experiments. The reported data of this mutagenicity assay shows that under the experimental conditions applied, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used. In conclusion, the test item LZ 754 has no mutagenic activity on the applied bacterium tester strains under the test conditions used in this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.